Detalhe da pesquisa
1.
Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells.
Gynecol Oncol;
144(2): 369-376, 2017 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27939982
2.
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.
J Natl Cancer Inst;
112(12): 1190-1203, 2020 12 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32413141
3.
Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.
Cancer Biol Ther;
20(6): 843-854, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30822218
4.
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.
Oncotarget;
9(25): 17735-17755, 2018 Apr 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29707144
5.
Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival.
J Cancer Res Clin Oncol;
142(6): 1239-52, 2016 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27028324
6.
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.
Orphanet J Rare Dis;
10: 32, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25886974
7.
p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.
Cancer Biol Ther;
14(10): 973-81, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24022213
8.
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
Nat Commun;
4: 1628, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23535649
9.
High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.
Cancer Genet;
205(3): 94-100, 2012 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22469508
10.
Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.
J Ovarian Res;
4(1): 20, 2011 Nov 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22075440